Latest immunotherapy news
.jpg)
ASCO GI: Zanidatamab + Chemo Beneficial in HER2-Positive Gastroesophageal Cancer
posted January 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Clonal Hematopoiesis of Indeterminate Potential Linked to CVD Risk
posted January 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
30 mg Peanut Protein Maintenance Ups Threshold of Reactivity Over Strict Avoidance in Peanut-Allergic Children
posted January 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Subcutaneous Rybrevant Faspro for EGFR-Mutated Non-Small Cell Lung Cancer
posted December 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions Related Articles
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported 
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL 
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors Monthly Specialist Briefings
Stay Connected
